Reuters - Pfizer Inc. said on Thursday
it has reached a deal with French drug maker Sanofi-Aventis
to acquire worldwide rights to the inhaled insulin
drug Exubera for $1.3 billion.
View the entire article:
Pfizer to gain Sanofi Exubera rights (Reuters)